FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Harland Sather

Research Profile

Disorders

Living Beings

Infants

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Anatomy

Bone Marrow

Co-author Network

Publications

TOP 3
ZoAnn E Dreyer; Patricia A Dinndorf; Bruce Camitta; Harland Sather; Mei K La; Meenakshi Devidas; Joanne M Hilden; Nyla A Heerema; Jean E Sanders; Ron McGlennen; Cheryl L Willman; Andrew J Carroll; Frederick G. Behm; Franklin O Smith; William G Woods; Kamar Godder; Gregory H Reaman
Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.
Linda C Stork; Yousif Matloub; Emmett Broxson; Mei K La; Rochelle Yanofsky; Harland Sather; Raymond J Hutchinson; Nyla A Heerema; April D Sorrell; Margaret Masterson; Archie Bleyer; Paul S Gaynon
Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.
Paul S Gaynon; A L Angiolillo; William L Carroll; James B Nachman; Michael E Trigg; Harland Sather; Stephen P Hunger; M Devidas
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Harland Sather (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: ZoAnn E Dreyer; Patricia A Dinndorf; Bruce Camitta; Harland Sather; Mei K La; Meenakshi Devidas; Joanne M Hilden; Nyla A Heerema; Jean E Sanders; Ron McGlennen; Cheryl L Willman; Andrew J Carroll; Frederick G. Behm; Franklin O Smith; William G Woods; Kamar Godder; Gregory H Reaman
Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(2):214-22.
2010: Linda C Stork; Yousif Matloub; Emmett Broxson; Mei K La; Rochelle Yanofsky; Harland Sather; Raymond J Hutchinson; Nyla A Heerema; April D Sorrell; Margaret Masterson; Archie Bleyer; Paul S Gaynon
Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.
Blood 2010;115(14):2740-8.
2010: Paul S Gaynon; A L Angiolillo; William L Carroll; James B Nachman; Michael E Trigg; Harland Sather; Stephen P Hunger; M Devidas
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.
Leukemia 2010;24(2):285-97.
2009: James B Nachman; Mei K La; Stephen P Hunger; Nyla A Heerema; Paul S Gaynon; Caroline Hastings; Leonard A Mattano; Harland Sather; Meenakshi Devidas; David R Freyer; Peter G Steinherz; Nita L Seibel
Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5189-94.
2009: Kirk R Schultz; W Paul Bowman; Alexander Aledo; William B Slayton; Harland Sather; Meenakshi Devidas; Chenguang Wang; Stella M Davies; Paul S Gaynon; Michael E Trigg; Robert Rutledge; Laura Burden; Dean Jorstad; Andrew Carroll; Nyla A Heerema; Naomi J Winick; Michael J Borowitz; Stephen P Hunger; William L Carroll; Bruce Camitta
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5175-81.
2008: Deepa Bhojwani; Huining Kang; Renee X Menezes; Wenjian Yang; Harland Sather; Naomi P Moskowitz; Dong-Joon Min; Jeffrey W Potter; Richard Harvey; Stephen P Hunger; Nita Seibel; Elizabeth A Raetz; Rob Pieters; Martin A Horstmann; Mary Relling; Monique L den Boer; Cheryl L Willman; William L Carroll
Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(27):4376-84.
2008: Deborah French; Leo H Hamilton; Leonard A Mattano; Harland Sather; Meenakshi Devidas; James B Nachman; Mary Relling
A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood 2008;111(9):4496-9.
2008: Nita L Seibel; Peter G Steinherz; Harland Sather; James B Nachman; Cynthia Delaat; Lawrence J Ettinger; David R Freyer; Leonard A Mattano; Caroline A Hastings; Charles M Rubin; Kathy Bertolone; Janet L Franklin; Nyla A Heerema; Torrey L Mitchell; Allan F Pyesmany; Mei K La; Cheryl Edens; Paul S Gaynon
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood 2008;111(5):2548-55.
2007: Suman Malempati; Paul S Gaynon; Harland Sather; Mei K La; Linda C Stork
Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5800-7.
2007: James B Nachman; Nyla A Heerema; Harland Sather; Bruce M Camitta; Erik Forestier; Christine J Harrison; Nicole Dastugue; Martin Schrappe; Ching-Hon Pui; Giuseppe Basso; Lewis B Silverman; Gritta E Janka-Schaub
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.
Blood 2007;110(4):1112-5.
2007: Anna M Butturini; Frederick J Dorey; Beverly J Lange; David W Henry; Paul S Gaynon; Cecilia Fu; Janet Franklin; Stuart E Siegel; Nita L Seibel; Paul C Rogers; Harland Sather; Michael E Trigg; Archie Bleyer; William L Carroll
Obesity and outcome in pediatric acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2063-9.
2007: Prakash Satwani; Harland Sather; Fevzi Ozkaynak; Nyla A Heerema; Kirk R Schultz; Jean Sanders; John Kersey; Virginia Davenport; Michael E Trigg; Mitchell S Cairo
Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(2):218-27.
2007: Kirk R Schultz; D Jeanette Pullen; Harland Sather; Jonathan J Shuster; Meenakshi Devidas; Michael J Borowitz; Andrew J Carroll; Nyla A Heerema; Jeffrey E Rubnitz; Mignon L Loh; Elizabeth A Raetz; Naomi J Winick; Stephen P Hunger; William L Carroll; Paul S Gaynon; Bruce M Camitta
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
Blood 2007;109(3):926-35.
2006: Paul C Nathan; Trish Whitcomb; Pamela L Wolters; Seth M Steinberg; FRANK BALIS; Pim Brouwers; Sally Hunsberger; James Feusner; Harland Sather; James S Miser; Lorrie F Odom; David G Poplack; Gregory Reaman; Archie Bleyer
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P.
Leukemia & lymphoma 2006;47(12):2488-504.
2006: Yousif Matloub; Susan J Lindemulder; Paul S Gaynon; Harland Sather; Mei K La; Emmett Broxson; Rochelle Yanofsky; Raymond J Hutchinson; Nyla A Heerema; James B Nachman; Marilyn Blake; Linda M Wells; April D Sorrell; Margaret Masterson; John F Kelleher; Linda C Stork
Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
Blood 2006;108(4):1165-73.
2006: Joanne M Hilden; Patricia A Dinndorf; Sharon O Meerbaum; Harland Sather; Doojduen Villaluna; Nyla A Heerema; Ron McGlennen; Franklin O Smith; William G Woods; Wanda L Salzer; Helen S Johnstone; Zoann Dreyer; Gregory H Reaman
Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.
Blood 2006;108(2):441-51.
2005: James A Whitlock; Harland Sather; Paul S Gaynon; Leslie L Robison; Robert J Wells; Michael E Trigg; Nyla A Heerema; Smita Bhatia
Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 2005;106(13):4043-9.
2005: Stephen P Hunger; Naomi J Winick; Harland Sather; William L Carroll
Therapy of low-risk subsets of childhood acute lymphoblastic leukemia: when do we say enough?
Pediatric blood & cancer 2005;45(7):876-80.
2005: Jakub Tolar; Bruce C Bostrom; Mei K La; Harland Sather
Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922.
Pediatric blood & cancer 2005;45(1):5-9.
2005: Douglas P Olson; Barbara J Taylor; Mei K La; Harland Sather; Gregory H Reaman; S Percy Ivy
The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group.
Leukemia & lymphoma 2005;46(5):681-91.
2005: M J Sutcliffe; Jonathan J Shuster; Harland Sather; Bruce M Camitta; Jeanette Pullen; Kirk R Schultz; Michael J Borowitz; P S Gaynon; Andrew J Carroll; N A Heerema
High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative.
Leukemia 2005;19(5):734-40.
2005: Mylène Bassal; Mei K La; James A Whitlock; Harland Sather; Nyla A Heerema; Paul S Gaynon; Linda C Stork
Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
Pediatric blood & cancer 2005;44(1):21-8.
2004: Nyla A Heerema; James B Nachman; Harland Sather; Mei K La; Raymond J Hutchinson; Beverly J Lange; Bruce C Bostrom; Peter G Steinherz; Paul S Gaynon; fatih uckun
Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group.
Leukemia 2004;18(5):939-47.
2004: Eduard H Panosyan; Nita L Seibel; Sagrario Martin-Aragon; Paul S Gaynon; Ioannis A Avramis; Harland Sather; Janet Franklin; James B Nachman; Lawrence J Ettinger; Mei K La; Peter G Steinherz; Lewis J Cohen; Stuart E Siegel; Vassilios I Avramis
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.
Journal of pediatric hematology/oncology 2004;26(4):217-26.
2004: Nyla A Heerema; Jochen Harbott; S Galimberti; Bruce M Camitta; Paul S Gaynon; Gritta E Janka-Schaub; W Kamps; G Basso; Ching-Hon Pui; Martin Schrappe; M-F Auclerc; Andrew J Carroll; Valentino Conter; Christine J Harrison; Jeanette Pullen; Susana C Raimondi; S Richards; Hansjörg Riehm; Harland Sather; Jonathan J Shuster; Lewis B Silverman; M G Valsecchi; M Aricò
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
Leukemia 2004;18(4):693-702.
2004: John P Perentesis; Smita Bhatia; E Boyle; Y Shao; X Ou Shu; M Steinbuch; Harland Sather; Paul S Gaynon; William R Kiffmeyer; J Envall-Fox; Leslie L Robison
RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia.
Leukemia 2004;18(4):685-92.
2003: Adam Levy; Harland Sather; Peter G Steinherz; Rebecca Sowers; Mei K La; Jeffrey A Moscow; Paul S Gaynon; fatih uckun; Joseph R Bertino; Richard Gorlick
Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study.
Journal of pediatric hematology/oncology 2003;25(9):688-95.
2003: Bruce C Bostrom; Martha R Sensel; Harland Sather; Paul S Gaynon; Mei K La; Katherine Johnston; Gary R Erdmann; Stuart Gold; Nyla A Heerema; Raymond J Hutchinson; Arthur J Provisor; Michael E Trigg
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Blood 2003;101(10):3809-17.
2003: Ursula R Kees; Nyla A Heerema; R Kumar; Paul M Watt; David L Baker; Mei K La; fatih uckun; Harland Sather
Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG).
Leukemia 2003;17(5):887-93.
2003: Raymond J Hutchinson; Paul S Gaynon; Harland Sather; Salvatore J Bertolone; Herbert Cooper; Raymond Tannous; Linda M Wells; Nyla A Heerema; Scott Sailer; Michael E Trigg
Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1790-7.
2003: John A Heath; Peter G Steinherz; Arnold Altman; Harland Sather; Suresh C Jhanwar; Steven Halpern; Richard Pieters; Narayan Shah; Laurel Steinherz; Raymond Tannous; William Terry; Michael E Trigg
Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1612-7.
2002: Smita Bhatia; Harland Sather; Nyla A Heerema; Michael E Trigg; Paul S Gaynon; Leslie L Robison
Racial and ethnic differences in survival of children with acute lymphoblastic leukemia.
Blood 2002;100(6):1957-64.
2002: Smita Bhatia; Harland Sather; Olga B Pabustan; Michael E Trigg; Paul S Gaynon; Leslie L Robison
Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.
Blood 2002;99(12):4257-64.
2002: Vassilios I Avramis; Susan F Sencer; Antonia P Periclou; Harland Sather; Bruce C Bostrom; Lewis J Cohen; Alice G Ettinger; Lawrence J Ettinger; Janet Franklin; Paul S Gaynon; Joanne M Hilden; Beverly Lange; Fataneh Majlessipour; Pracad Mathew; Michael Neil Needle; Joseph P Neglia; Gregory Reaman; John Holcenberg; Linda C Stork
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 2002;99(6):1986-94.
2002: Nyla A Heerema; Harland Sather; Martha G Sensel; Mei K La; Raymond J Hutchinson; James B Nachman; Gregory H Reaman; Beverly J Lange; Peter G Steinherz; Bruce C Bostrom; Paul S Gaynon; fatih uckun
Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia.
Cancer 2002;94(4):1102-10.
2002: Beverly J Lange; Bruce C Bostrom; Joel M Cherlow; Martha G Sensel; Mei K La; Wayne Rackoff; Nyla A Heerema; Robert S Wimmer; Michael E Trigg; Harland Sather
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Blood 2002;99(3):825-33.
2001: fatih uckun; N Pallisgaard; Peter Hokland; Christopher S Navara; Rama Krishna Narla; Paul S Gaynon; Harland Sather; Nyla A Heerema
Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia.
Leukemia & lymphoma 2001;42(1-2):41-56.
2001: Paul S Gaynon; Bruce C Bostrom; Raymond J Hutchinson; Beverly J Lange; James B Nachman; Peter G Steinherz; Martha G Sensel; M K Lee; D O Stram; Harland Sather
Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1916-25.
2001: Tina L Carter; Paul M Watt; R Kumar; P R Burton; Gregory H Reaman; Harland Sather; David L Baker; Ursula R Kees
Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse.
Blood 2001;97(2):572-4.
2000: Paul S Gaynon; Michael E Trigg; N A Heerema; Martha G Sensel; Harland Sather; G D Hammond; Archie Bleyer
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.
Leukemia 2000;14(12):2223-33.
2000: N A Heerema; Harland Sather; Martha G Sensel; M K Lee; Raymond J Hutchinson; James B Nachman; Gregory H Reaman; Beverly J Lange; Peter G Steinherz; Bruce C Bostrom; Paul S Gaynon; fatih uckun
Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3837-44.
2000: L A Mattano; Harland Sather; Michael E Trigg; James B Nachman
Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(18):3262-72.
2000: fatih uckun; Linda C Stork; Nita L Seibel; MB Sarquis; C Bedros; Harland Sather; Martha G Sensel; Gregory H Reaman; Paul S Gaynon
Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3123-30.
2000: N A Heerema; Harland Sather; Martha G Sensel; T Zhang; Raymond J Hutchinson; James B Nachman; Beverly J Lange; Peter G Steinherz; Bruce C Bostrom; Gregory H Reaman; Paul S Gaynon; fatih uckun
Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1876-87.
2000: Nyla A Heerema; Harland Sather; Martha G Sensel; MK Lee; Raymond J Hutchinson; James B Nachman; Beverly J Lange; Peter G Steinherz; Bruce C Bostrom; Paul S Gaynon; fatih uckun
Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Cancer 2000;88(8):1945-54.
2000: Nyla A Heerema; Harland Sather; Martha G Sensel; MK Lee; Raymond J Hutchinson; Beverly J Lange; Bruce C Bostrom; James B Nachman; Peter G Steinherz; Paul S Gaynon; fatih uckun
Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Leukemia & lymphoma 2000;36(5-6):467-78.
2000: Michael E Trigg; Peter G Steinherz; R Chappell; Helen S Johnstone; Paul S Gaynon; John H Kersey; Joel M Cherlow; N J Grossman; Harland Sather; G D Hammond
Early testicular biopsy in males with acute lymphoblastic leukemia: lack of impact on subsequent event-free survival.
Journal of pediatric hematology/oncology 2000;22(1):27-33.
1999: Nyla A Heerema; James B Nachman; Harland Sather; Martha G Sensel; MK Lee; Raymond J Hutchinson; Beverly J Lange; Peter G Steinherz; Bruce C Bostrom; Paul S Gaynon; fatih uckun
Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group.
Blood 1999;94(12):4036-45.
1999: L Sun; Patricia A Goodman; C M Wood; ML Crotty; Martha G Sensel; Harland Sather; Christopher S Navara; James B Nachman; Peter G Steinherz; Paul S Gaynon; Nita L Seibel; Alexei O Vassilev; B D Juran; Gregory H Reaman; fatih uckun
Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(12):3753-66.
1999: F M Wiley; Kathleen Sue Ruccione; I M Moore; P McGuire-Cullen; J Fergusson; M J Waskerwitz; G Perin; J Ge; Harland Sather
Parents' perceptions of randomization in pediatric clinical trials. Children Cancer Group.
Cancer practice 1999;7(5):248-56.
1999: Nyla A Heerema; Harland Sather; Martha G Sensel; Wen Liu; Beverly J Lange; Bruce C Bostrom; James B Nachman; Peter G Steinherz; Raymond J Hutchinson; Paul S Gaynon; Diane C Arthur; fatih uckun
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group.
Blood 1999;94(5):1537-44.
1999: L Sun; ML Crotty; Martha G Sensel; Harland Sather; Christopher S Navara; James B Nachman; Peter G Steinherz; Paul S Gaynon; Nita L Seibel; C Mao; Alexei O Vassilev; Gregory H Reaman; fatih uckun
Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2112-20.
1999: W R Rackoff; J Ge; Harland Sather; Herbert Cooper; Raymond J Hutchinson; Beverly J Lange
Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Journal of pediatric hematology/oncology 1999;21(4):260-7.
1999: Nyla A Heerema; Harland Sather; J Ge; Diane C Arthur; Joanne M Hilden; Michael E Trigg; Gregory H Reaman
Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer Group.
Leukemia 1999;13(5):679-86.
1999: fatih uckun; James B Nachman; Harland Sather; Martha G Sensel; P Kraft; Peter G Steinherz; B Lange; Raymond J Hutchinson; Gregory H Reaman; Paul S Gaynon; Nyla A Heerema
Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy.
Leukemia & lymphoma 1999;33(1-2):101-6.
1999: Gregory H Reaman; Richard Sposto; Martha G Sensel; Beverly J Lange; James Feusner; Nyla A Heerema; M Leonard; Emiko J Holmes; Harland Sather; T W Pendergrass; Helen S Johnstone; R T O'Brien; Peter G Steinherz; Paul M Zeltzer; Paul S Gaynon; Michael E Trigg; fatih uckun
Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):445-55.
1999: fatih uckun; Barbara Waurzyniak; Harland Sather; Martha G Sensel; LM Chelstrom; James B Nachman; Paul S Gaynon; Bruce C Bostrom; O Ek; MB Sarquis; Peter G Steinherz; Gregory H Reaman
Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group study.
Leukemia & lymphoma 1999;32(5-6):475-87.
1998: Barbara Waurzyniak; Nyla A Heerema; Martha G Sensel; Paul S Gaynon; P Kraft; Harland Sather; LM Chelstrom; Gregory H Reaman; fatih uckun
Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID mice.
Leukemia & lymphoma 1998;32(1-2):77-87.
1998: FRANK BALIS; John Holcenberg; David G Poplack; J Ge; Harland Sather; RF Murphy; M M Ames; M J Waskerwitz; DG Tubergen; S Zimm; G S Gilchrist; Archie Bleyer
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
Blood 1998;92(10):3569-77.
1998: fatih uckun; James B Nachman; Harland Sather; Martha G Sensel; P Kraft; Peter G Steinherz; B Lange; Raymond J Hutchinson; Gregory H Reaman; Paul S Gaynon; Nyla A Heerema
Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group.
Cancer 1998;83(9):2030-9.
1998: fatih uckun; Harland Sather; Barbara Waurzyniak; Martha G Sensel; LM Chelstrom; O Ek; MB Sarquis; James B Nachman; Bruce C Bostrom; Gregory H Reaman; Paul S Gaynon
Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group Study.
Leukemia & lymphoma 1998;30(5-6):503-14.
1998: fatih uckun; K Herman-Hatten; ML Crotty; Martha G Sensel; Harland Sather; L Tuel-Ahlgren; MB Sarquis; Bruce C Bostrom; James B Nachman; Peter G Steinherz; Paul S Gaynon; Nyla A Heerema
Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation.
Blood 1998;92(3):810-21.
1998: James B Nachman; Harland Sather; Martha G Sensel; Michael E Trigg; Joel M Cherlow; John Lukens; L Wolff; fatih uckun; Paul S Gaynon
Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.
The New England journal of medicine 1998;338(23):1663-71.
1998: Nyla A Heerema; Harland Sather; Martha G Sensel; P Kraft; James B Nachman; Peter G Steinherz; Beverly J Lange; Raymond J Hutchinson; Gregory H Reaman; Michael E Trigg; Diane C Arthur; Paul S Gaynon; fatih uckun
Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1270-8.
1998: R E Harris; Harland Sather; S A Feig
High-dose cytosine arabinoside and L-asparaginase in refractory acute lymphoblastic leukemia: the Children's Cancer Group experience.
Medical and pediatric oncology 1998;30(4):233-9.
1998: James B Nachman; Harland Sather; Joel M Cherlow; Martha G Sensel; Paul S Gaynon; John Lukens; L Wolff; Michael E Trigg
Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):920-30.
1998: fatih uckun; Martha G Sensel; Harland Sather; Paul S Gaynon; Diane C Arthur; Beverly J Lange; Peter G Steinherz; P Kraft; Raymond J Hutchinson; James B Nachman; Gregory H Reaman; Nyla A Heerema
Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):527-35.
1998: Peter G Steinherz; Paul S Gaynon; John C. Breneman; Joel M Cherlow; N J Grossman; John H Kersey; Helen S Johnstone; Harland Sather; Michael E Trigg; fatih uckun; Archie Bleyer
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
Cancer 1998;82(3):600-12.
1998: fatih uckun; Martha G Sensel; L Sun; Peter G Steinherz; Michael E Trigg; Nyla A Heerema; Harland Sather; Gregory H Reaman; Paul S Gaynon
Biology and treatment of childhood T-lineage acute lymphoblastic leukemia.
Blood 1998;91(3):735-46.
1997: S A Feig; R E Harris; Harland Sather
Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the Children's Cancer Group (CCG-1884).
Medical and pediatric oncology 1997;29(6):534-40.
1997: fatih uckun; Harland Sather; Paul S Gaynon; D Arthur; James B Nachman; Martha G Sensel; Peter G Steinherz; Raymond J Hutchinson; Michael E Trigg; Gregory Reaman
Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Leukemia & lymphoma 1997;27(5-6):445-57.
1997: Paul S Gaynon; A A Desai; Bruce C Bostrom; Raymond J Hutchinson; Beverly J Lange; James B Nachman; Gregory H Reaman; Harland Sather; Peter G Steinherz; Michael E Trigg; DG Tubergen; fatih uckun
Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review.
Cancer 1997;80(9):1717-26.
1997: fatih uckun; Harland Sather; Paul S Gaynon; Diane C Arthur; Michael E Trigg; DG Tubergen; James B Nachman; Peter G Steinherz; Martha G Sensel; Gregory H Reaman
Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Blood 1997;90(1):28-35.
1997: Paul S Gaynon; ML Crotty; Harland Sather; Bruce C Bostrom; James B Nachman; Peter G Steinherz; Nyla A Heerema; MB Sarquis; L Tuel-Ahlgren; fatih uckun
Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: a Children's Cancer Group initiative.
Leukemia & lymphoma 1997;26(1-2):57-65.
1997: James B Nachman; Harland Sather; Paul S Gaynon; John Lukens; L Wolff; Michael E Trigg
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2222-30.
1997: fatih uckun; Paul S Gaynon; Martha G Sensel; James B Nachman; Michael E Trigg; Peter G Steinherz; Raymond J Hutchinson; Bruce C Bostrom; Harland Sather; Gregory H Reaman
Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2214-21.
1997: fatih uckun; Z Yang; Harland Sather; Peter G Steinherz; James B Nachman; Bruce C Bostrom; L Crotty; MB Sarquis; O Ek; T Zeren; DG Tubergen; Gregory Reaman; Paul S Gaynon
Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
Blood 1997;89(10):3769-77.
1997: fatih uckun; Paul S Gaynon; Harland Sather; D Arthur; Michael E Trigg; DG Tubergen; James B Nachman; Peter G Steinherz; Martha G Sensel; G R Reaman
Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 1997;89(7):2488-93.
1996: fatih uckun; Gregory Reaman; P G Steinherez; Diane C Arthur; Harland Sather; Michael E Trigg; DG Tubergen; Paul S Gaynon
Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study.
Leukemia & lymphoma 1996;24(1-2):57-70.
1996: fatih uckun; Peter G Steinherz; Harland Sather; Michael E Trigg; D Arthur; DG Tubergen; Paul S Gaynon; Gregory Reaman
CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 1996;88(11):4288-95.
1996: Stephen A Feig; Matthew M Ames; Harland Sather; L Steinherz; Joel M Reid; Michael E Trigg; T W Pendergrass; P Warkentin; M Gerber; M Leonard; Archie Bleyer; R E Harris
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.
Medical and pediatric oncology 1996;27(6):505-14.
1996: Joel M Cherlow; Harland Sather; Peter G Steinherz; Paul S Gaynon; DG Tubergen; Michael E Trigg; L Novak; Archie Bleyer
Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: a report from the Children's Cancer Group.
International journal of radiation oncology, biology, physics 1996;36(1):19-27.
1996: Peter G Steinherz; Paul S Gaynon; John C. Breneman; Joel M Cherlow; N J Grossman; J H Kersey; Helen S Johnstone; Harland Sather; Michael E Trigg; R Chappell; D Hammond; Archie Bleyer
Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):389-98.
1996: M Smith; D Arthur; Bruce M Camitta; Andrew J Carroll; William M Crist; Paul S Gaynon; R Gelber; N Heerema; Edward L Korn; Michael Link; S Murphy; Ching-Hon Pui; Jeanette Pullen; G Reamon; Stephen E Sallan; Harland Sather; J Shuster; Richard Simon; Michael E Trigg; DG Tubergen; fatih uckun; R Ungerleider
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):18-24.
1995: fatih uckun; Harland Sather; Gregory Reaman; J Shuster; V Land; Michael E Trigg; R Gunther; LM Chelstrom; A Bleyer; Paul S Gaynon
Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.
Blood 1995;85(4):873-8.
1994: G S Gilchrist; DG Tubergen; Harland Sather; Peter F Coccia; R T O'Brien; M J Waskerwitz; G D Hammond
Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2594-600.
1994: Xiao-Ou Shu; Gregory H Reaman; B Lampkin; Harland Sather; T W Pendergrass; L L Robison
Association of paternal diagnostic X-ray exposure with risk of infant leukemia. Investigators of the Childrens Cancer Group.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(8):645-53.
1994: Jonathan D Buckley; C M Buckley; Kathleen Sue Ruccione; Harland Sather; M J Waskerwitz; William G Woods; Leslie L Robison
Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Childrens Cancer Group.
Leukemia 1994;8(5):856-64.
1994: Nyla A Heerema; Diane C Arthur; Harland Sather; V Albo; J Feusner; Beverly J Lange; Peter G Steinherz; P Zeltzer; D Hammond; Gregory H Reaman
Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group.
Blood 1994;83(8):2274-84.
1993: Joel M Cherlow; Peter G Steinherz; Harland Sather; Paul S Gaynon; N J Grossman; J H Kersey; Helen S Johnstone; John C. Breneman; Michael E Trigg; G D Hammond
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
International journal of radiation oncology, biology, physics 1993;27(5):1001-9.
1993: James B Nachman; Harland Sather; Jonathan D Buckley; Paul S Gaynon; Peter G Steinherz; DG Tubergen; BC Lampkin; G D Hammond
Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment.
Cancer 1993;71(10 Suppl):3377-85.
1993: DG Tubergen; G S Gilchrist; R T O'Brien; Peter F Coccia; Harland Sather; M J Waskerwitz; G D Hammond
Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):527-37.
1993: DG Tubergen; G S Gilchrist; R T O'Brien; Peter F Coccia; Harland Sather; M J Waskerwitz; G D Hammond
Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):520-6.
1991: Archie Bleyer; Harland Sather; H J Nickerson; Peter F. Coccia; Jerry Z Finklestein; D R Miller; P S Littman; J N Lukens; Stuart E Siegel; G D Hammond
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(6):1012-21.
1991: Paul S Gaynon; Peter G Steinherz; Archie Bleyer; Jerry Z Finklestein; D R Miller; Gregory H Reaman; Harland Sather; G D Hammond
Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.
Medical and pediatric oncology 1991;19(4):221-7.
1991: W R Balsom; Archie Bleyer; L L Robison; R Heyn; A T Meadows; A Sitarz; Julie Blatt; Harland Sather; G D Hammond
Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group study.
Medical and pediatric oncology 1991;19(6):486-92.
1990: A E Evans; G J D'Angio; Harland Sather; A A de Lorimier; A Dalton; R S Ungerleider; Jerry Z Finklestein; G D Hammond
A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(4):678-88.
1990: James B Nachman; N F Palmer; Harland Sather; Archie Bleyer; Peter F. Coccia; John Lukens; Stuart E Siegel; G D Hammond
Open-wedge testicular biopsy in childhood acute lymphoblastic leukemia after two years of maintenance therapy: diagnostic accuracy and influence on outcome--a report from Children's Cancer Study Group.
Blood 1990;75(5):1051-5.
1990: Paul S Gaynon; Archie Bleyer; Peter G Steinherz; Jerry Z Finklestein; P Littman; D R Miller; Gregory Reaman; Harland Sather; G D Hammond
Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.
Medical and pediatric oncology 1990;18(4):273-9.
1990: D R Miller; S L Leikin; V C Albo; N F Palmer; Harland Sather; G D Hammond
The prognostic value of testicular biopsy in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(1):57-66.
1989: D R Miller; Peter F. Coccia; Archie Bleyer; J N Lukens; Stuart E Siegel; Harland Sather; G D Hammond
Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(12):1807-15.
1989: Jonathan D Buckley; G S Gilchrist; Kathleen Sue Ruccione; Harland Sather; William G Woods; G D Hammond
Multiple sclerosis in mothers of children with acute lymphoblastic leukemia.
Leukemia 1989;3(10):736-9.
1989: Jonathan D Buckley; Harland Sather; Kathleen Sue Ruccione; P C Rogers; J E Haas; Brian Henderson; G D Hammond
A case-control study of risk factors for hepatoblastoma. A report from the Childrens Cancer Study Group.
Cancer 1989;64(5):1169-76.
1988: H S Maurer; Peter G Steinherz; Paul S Gaynon; Jerry Z Finklestein; Harland Sather; Gregory H Reaman; Archie Bleyer; G D Hammond
The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(9):1425-32.
1988: R J Wells; P K Weck; R L Baehner; W Krivit; R B Raney; J A Ortega; I O Bernstein; B Lampkin; J K Whisnant; Harland Sather
Interferon-alpha n1 in children with recurrent acute lymphocytic leukemia: a phase I study of pharmacokinetics and tolerance.
Journal of interferon research 1988;8(3):309-18.
1988: M Matsumura; J B Atkinson; D M Hays; G D Hammond; Stuart E Siegel; Harland Sather; J Grosfeld; G Haase
An evaluation of the role of surgery in metastatic neuroblastoma.
Journal of pediatric surgery 1988;23(5):448-53.
1988: Paul S Gaynon; Archie Bleyer; Peter G Steinherz; Jerry Z Finklestein; P S Littman; D R Miller; Gregory H Reaman; Harland Sather; G D Hammond
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P.
The American journal of pediatric hematology/oncology 1988;10(1):42-50.
1987: Gregory H Reaman; Peter G Steinherz; Paul S Gaynon; Archie Bleyer; Jerry Z Finklestein; R Evans; D R Miller; Harland Sather; G D Hammond
Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.
Cancer treatment reports 1987;71(11):1033-8.
1987: P Littman; P Coccia; Archie Bleyer; J Lukens; Stuart E Siegel; D Miller; Harland Sather; D Hammond
Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL).
International journal of radiation oncology, biology, physics 1987;13(10):1443-9.
1987: Paul S Gaynon; E S Baum; C Samsel; Harland Sather
Microcomputer-assisted data management for multiinstitutional pediatric clinical cancer trials.
The American journal of pediatric hematology/oncology 1987;9(1):33-41.
1987: P S Gaynon; Peter G Steinherz; G H Reaman; W A Bleyer; Harland Sather; G D Hammond
Strategies for the treatment of children with acute lymphoblastic leukemia and unfavorable presenting features.
Haematology and blood transfusion 1987;30():167-72.
1987: G D Hammond; Harland Sather; Archie Bleyer; P Coccia
Stratification by prognostic factors in the design and analysis of clinical trials for acute lymphoblastic leukemia.
Haematology and blood transfusion 1987;30():161-6.
1986: Peter G Steinherz; Paul S Gaynon; D R Miller; Gregory Reaman; A Bleyer; Jerry Z Finklestein; R G Evans; Paul A Meyers; L J Steinherz; Harland Sather
Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(5):744-52.
1986: R Mastrangelo; David G Poplack; A Bleyer; R Riccardi; Harland Sather; G D'Angio
Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment.
Medical and pediatric oncology 1986;14(3):191-4.
1986: Archie Bleyer; Harland Sather; P Coccia; J Lukens; Stuart E Siegel; G D Hammond
The staging of childhood acute lymphoblastic leukemia: strategies of the Childrens Cancer Study Group and a three-dimensional technic of multivariate analysis.
Medical and pediatric oncology 1986;14(5):271-80.
1986: D Hammond; Harland Sather; M Nesbit; D Miller; P Coccia; A Bleyer; J Lukens; Stuart E Siegel
Analysis of prognostic factors in acute lymphoblastic leukemia.
Medical and pediatric oncology 1986;14(3):124-34.
1985: Gregory Reaman; P Zeltzer; Archie Bleyer; B Amendola; C Level; Harland Sather; D Hammond
Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(11):1513-21.
1984: P Littman; J Rosenstock; G Gale; R E Krisch; A Meadows; Harland Sather; P Coccia; B DeCamargo
The somnolence syndrome in leukemic children following reduced daily dose fractions of cranial radiation.
International journal of radiation oncology, biology, physics 1984;10(10):1851-3.
1984: L L Robison; M E Nesbit; Harland Sather; C Level; N Shahidi; A Kennedy; D Hammond
Down syndrome and acute leukemia in children: a 10-year retrospective survey from Childrens Cancer Study Group.
The Journal of pediatrics 1984;105(2):235-42.
1984: P C Rogers; Archie Bleyer; P Coccia; J N Lukens; Stuart E Siegel; Harland Sather; D Hammond
Yield of unpredicted bone-marrow relapse diagnosed by routine marrow aspiration in children with acute lymphoblastic leukaemia. A report from the Children's Cancer Study Group.
Lancet 1984;1(8390):1320-2.
1983: Archie Bleyer; Peter F. Coccia; Harland Sather; C Level; J Lukens; D J Niebrugge; Stuart E Siegel; P S Littman; S L Leikin; D R Miller
Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(5):317-25.
1983: A Sitarz; Jerry Z Finklestein; J Grosfeld; S Leikin; S Mc Creadie; M Klemperer; I Bernstein; Harland Sather; D Hammond
An evaluation of the role of surgery in disseminated neuroblastoma: a report from the Children's Cancer Study Group.
Journal of pediatric surgery 1983;18(2):147-51.
1983: D R Miller; S Leikin; V Albo; Harland Sather; M Karon; D Hammond
Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from childrens cancer study group.
Cancer 1983;51(6):1041-9.
1983: E Baum; J Nachman; N Ramsay; B Weetman; R Neerhout; P Littman; T Griffin; D Norris; Harland Sather
Prolonged second remissions in childhood acute lymphocytic leukemia: a report from the Childrens Cancer Study Group.
Medical and pediatric oncology 1983;11(1):1-7.
1982: R Heyn; W Krivit; Harland Sather; D Hammond
Evaluation of azapicyl in soft tissue sarcomas in children: a report from the Children's Cancer Study Group.
Cancer treatment reports 1982;66(2):399-401.
1982: M E Nesbit; Harland Sather; L L Robison; M Donaldson; P Littman; J A Ortega; G D Hammond
Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
Cancer research 1982;42(2):674-80.
1981: S Leikin; D Miller; Harland Sather; V Albo; E Esber; A Johnson; N Rogentine; D Hammond
Immunologic evaluation in the prognosis of acute lymphoblastic leukemia. A report from Childrens Cancer Study Group.
Blood 1981;58(3):501-8.
1981: G J D'Angio; P Littman; M Nesbit; Harland Sather; R Hittle; J Ortega; M Donaldson; D Hammond
Evaluation of radiation therapy factors in prophylactic central nervous system irradiation for childhood leukemia: a report from the Children's Cancer Study Group.
International journal of radiation oncology, biology, physics 1981;7(8):1031-8.
1981: Harland Sather; P Coccia; M Nesbit; C Level; D Hammond
Disappearance of the predictive value of prognostic variables in childhood acute lymphoblastic leukemia: a report from Childrens Cancer Study Group.
Cancer 1981;48(2):370-6.
1981: D R Miller; S Leikin; V Albo; Harland Sather; D Hammond
Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL).
British journal of haematology 1981;48(2):199-206.
1981: Harland Sather; D Miller; M Nesbit; R Heyn; D Hammond
Differences in prognosis for boys and girls with acute lymphoblastic leukaemia.
Lancet 1981;1(8223):739-43.
1981: M E Nesbit; Harland Sather; L L Robison; J Ortega; P S Littman; G J D'Angio; G D Hammond
Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group.
Lancet 1981;1(8218):461-6.
1981: D R Miller; S Leikin; V Albo; Harland Sather; M Karon; D Hammond
Intensive therapy and prognostic factors in acute lymphoblastic leukemia of childhood:CCG 141. A report from Childrens Cancer Study Group.
Haematology and blood transfusion 1981;26():77-86.
1980: D R Miller; S Leikin; V Albo; L Vitale; Harland Sather; P Coccia; M Nesbit; M Karon; D Hammond
Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group Report.
Cancer treatment reports 1980;64(2-3):381-92.